
Darzalex Faspro has been approved by the FDA in combination with pomalidomide and dexamethasone.
The approval applies to use in adult patients suffering from relapsing bone marrow cancer, also known as myelomatosis, who have previously received treatment.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app